Abivax (AAVXF) Interest Coverage Ratio Growth (1y) (2025)
Powered by 
Analysis
Abivax (AAVXF) Interest Coverage Ratio Growth (1y) (2025) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 211.77 Bn | 197.79 Bn | 7.24 Bn | 36.43% |
| 2 | Gilead Sciences | 181.13 Bn | 177.95 Bn | 6.22 Bn | -532.04% |
| 3 | Vertex Pharmaceuticals | 132.24 Bn | 124.39 Bn | 2.84 Bn | - |
| 4 | Regeneron Pharmaceuticals | 82.89 Bn | 74.89 Bn | 3.93 Bn | -60.78% |
| 5 | Argenx Se | 61.56 Bn | 56.38 Bn | 1.37 Bn | 176.09% |
| 6 | Moderna | 54.38 Bn | 49.24 Bn | 52.00 Mn | - |
| 7 | Alnylam Pharmaceuticals | 34.44 Bn | 31.13 Bn | 992.69 Mn | 1,170.12% |
| 8 | Biogen | 31.17 Bn | 29.89 Bn | 1.96 Bn | - |
| 9 | Roivant Sciences | 30.12 Bn | 30.12 Bn | 1.16 Mn | - |
| 10 | Abivax | 10.92 Bn | 10.92 Bn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 87.12% |
| Sep 30, 2025 | -95.72% |
| Jun 30, 2025 | 684.20% |
| Mar 31, 2025 | -10.96% |